Search

Search Constraints

You searched for: Author/Creator Wang, Yuan-Jen

Search Results

1. A 12-week rescue therapy by PrOD-based regimen for advanced fibrotic genotype-1 CHC patients who failed to pegylated interferon plus ribavirin. Issue 3 (March 2019)

2. Daclatasvir plus sofosbuvir, with or without ribavirin, is highly effective for all kinds of genotype-2 chronic hepatitis-C infection in Taiwan. Issue 9 (September 2019)

3. Durability of Nucleos(t)ide Analogues Treatment in Patients With Chronic Hepatitis B. Issue 32 (August 2015)

4. Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease. (17th January 2017)

5. Highly effective treatment response and well tolerability by all oral direct acting antivirals for chronic hepatitis C patients post organ transplantation. Issue 1 (January 2020)

6. Persistent liver inflammation in chronic hepatitis C patients with advanced fibrosis after direct-acting antivirals induced sustained virological response. Issue 5 (30th April 2021)

7. Prolonged sitting time links to subclinical atherosclerosis. Issue 1 (6th January 2022)

9. Sofosbuvir-based antiviral therapy provided highly treatment efficacy, safety, and good tolerability for Taiwanese chronic hepatitis C patients with decompensated cirrhosis. Issue 2 (11th November 2021)

10. Well tolerability and highly effective treatment response for hepatitis C virus-human immunodeficiency virus–coinfected patients treated by all-oral direct-acting antivirals. Issue 5 (30th April 2021)